Multiple Sclerosis, Chronic Progressive  >>  mitoxantrone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mitoxantrone / Generic mfg.
NCT00146159: Study Evaluating Mitoxantrone in Multiple Sclerosis

Terminated
3
336
Europe
Mitoxantrone
Wyeth is now a wholly owned subsidiary of Pfizer
Secondary Progressive Multiple Sclerosis
09/07
 

Download Options